Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

CUSIP: 83422E204

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+514,654
Put/Call ratio
6604%
SEC-reported price per share
$4.74
Number of holders
35
Value change
+$2,205,404
Number of buys
17
Open additional details 1 more signal available
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
111,445,611

Security key

83422E204

Report period

Q1 2023

Institutions

35

Top holders

10

Ownership snapshot

Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F 3/4/5 Highest disclosed value: $18,808,120 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $18.81M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $18.81M
RA CAPITAL MANAGEMENT, L.P. $18.43M
Bain Capital Life Sciences Invest... $16.84M
Camber Capital Management LP $7.63M
Laurion Capital Management LP $4.99M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$18,808,120
3,495,933 shares
— 31 Dec 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$18,433,419
3,426,286 shares
— 31 Dec 2022
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
denominator unverified
$16,842,000
3,130,422 shares
— 31 Dec 2022
Camber Capital Management LP
13F
Company
13F
—
denominator unverified
$7,631,000
1,418,439 shares
— 31 Dec 2022
Laurion Capital Management LP
13F
Company
13F
—
denominator unverified
$4,993,549
928,169 shares
— 31 Dec 2022
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$4,892,000
909,219 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
35
Shares
15,773,407
Rows available
35
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
35
Q1 2023 holders
35
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .